- Develop ligand-binding methods including immunoassays and or cell-based assays.- Evaluate and solve critical hurdles in method development- Perform validation and sample analysis according to GLP regulations

BioAuxilium is an R&D service provider for the pharmaceutical, biomedical and biotech industries, as well as academic research groups. We provide a range of high-quality, customized assay development services across a number of therapeutic areas on various technology platforms.Our mission is to provide the highest quality R&D services by helping our customers advance their assay development projects in a timely and cost effective manner.

• On > Point Biomolecular custom services: Development of customized assays (in vitro or cell-based) for worldwide pharma and biotech customers using AlphaLISA/AlphaScreen and other technologies. Capture customer needs and participate in creating project proposals. Plan and execute multiple projects under tight schedule. Write development reports and overview successful assay transfer.• Business development & sales support activities: customers visits and introduction to PerkinElmer technology offering.• Participate in redaction of technical guides and serve as technical expertise for field application specialists. Plan and execute technical trainings for potential customers, sales specialists and collaborators.• Organize monthly scientific meeting for the R&D department. Sustaining engineeringMajor accomplishments:• Successful execution of multiple custom OnPoint assays led to substantial pull-through revenues following customer adoption of PerkinElmer technologies.• Introduction of innovative cell-based assays in the field of Alzheimer’s and Huntington diseases which led to 3 posters presented to recent conferences (2010 through 2013)

• Development of several new products and technologies aiming at the drug discovery/high-throughput screening market. As a team member, execute R&D projects originating from the human health business unit using PACE methodologies and ISO 9001:2000 compliant environments. Launched the AlphaScreen GSH Donor beads wit related poster and publications. Released the new LANCE Ultra peptides catalog and the cGMP AlphaScreen kit

Developed new G-proteins coupled receptors for commercialization including membrane preparations product lines (SignalScreen™ and Membranes Target System™). Developed innovative technologies related to high throughput screening: ScreenReady Target™. Worked on HTS screening contracts service and assay development.

Study on tobacco carcinogens: Inhibition of lung tumorigenesis by NSAIDS. Andre Castonguay Lab